Literature DB >> 17284095

Lack of insight in schizophrenia: impact on treatment adherence.

Peter F Buckley1, Donna A Wirshing, Prameet Bhushan, Joseph M Pierre, Seth A Resnick, William C Wirshing.   

Abstract

People with schizophrenia commonly lack insight, that is, they are unaware of their illness and the consequences thereof. One of the most important consequences of lack of insight is a failure to recognise the need for treatment, leading to treatment nonadherence. With several scales that now enable objective measurement of insight, it is possible to examine correlates of insight change, including course of illness and treatment adherence. Specific interventions, both pharmacological and psychotherapeutic, have been developed to enhance illness insight and treatment adherence. The extent to which second-generation antipsychotic medications, including a recently released long-acting formulation, improve insight and/or enhance treatment adherence remains to be determined.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17284095     DOI: 10.2165/00023210-200721020-00004

Source DB:  PubMed          Journal:  CNS Drugs        ISSN: 1172-7047            Impact factor:   5.749


  82 in total

Review 1.  Interventions to improve medication adherence in schizophrenia.

Authors:  Annette Zygmunt; Mark Olfson; Carol A Boyer; David Mechanic
Journal:  Am J Psychiatry       Date:  2002-10       Impact factor: 18.112

2.  Early insight predicts depression and attempted suicide after 4 years in first-episode schizophrenia and schizophreniform disorder.

Authors:  N Crumlish; P Whitty; M Kamali; M Clarke; S Browne; O McTigue; A Lane; A Kinsella; C Larkin; E O'Callaghan
Journal:  Acta Psychiatr Scand       Date:  2005-12       Impact factor: 6.392

Review 3.  Cognitive behavior therapy for schizophrenia.

Authors:  Douglas Turkington; David Kingdon; Peter J Weiden
Journal:  Am J Psychiatry       Date:  2006-03       Impact factor: 18.112

4.  Attitudes toward antipsychotic medication: the impact of clinical variables and relationships with health professionals.

Authors:  Jennifer C Day; Richard P Bentall; Chris Roberts; Fiona Randall; Anne Rogers; Dinah Cattell; David Healy; Pam Rae; Cheryl Power
Journal:  Arch Gen Psychiatry       Date:  2005-07

5.  Cognitive approach to depression and suicidal thinking in psychosis. 1. Ontogeny of post-psychotic depression.

Authors:  M Birchwood; Z Iqbal; P Chadwick; P Trower
Journal:  Br J Psychiatry       Date:  2000-12       Impact factor: 9.319

6.  Surgically implantable long-term antipsychotic delivery systems for the treatment of schizophrenia.

Authors:  Steven J Siegel; Karen I Winey; Raquel E Gur; Robert H Lenox; Warren B Bilker; Debbie Ikeda; Neel Gandhi; Wen-Xiao Zhang
Journal:  Neuropsychopharmacology       Date:  2002-06       Impact factor: 7.853

7.  Why do schizophrenic patients refuse to take their drugs?

Authors:  T Van Putten
Journal:  Arch Gen Psychiatry       Date:  1974-07

8.  Comparative evaluation of conventional and novel antipsychotic drugs with reference to their subjective tolerability, side-effect profile and impact on quality of life.

Authors:  L Voruganti; L Cortese; L Oyewumi; Z Cernovsky; S Zirul; A Awad
Journal:  Schizophr Res       Date:  2000-06-16       Impact factor: 4.939

9.  Skills training versus psychosocial occupational therapy for persons with persistent schizophrenia.

Authors:  R P Liberman; C J Wallace; G Blackwell; A Kopelowicz; J V Vaccaro; J Mintz
Journal:  Am J Psychiatry       Date:  1998-08       Impact factor: 18.112

10.  Pharmacy data identify poorly adherent patients with schizophrenia at increased risk for admission.

Authors:  Marcia Valenstein; Laurel A Copeland; Frederic C Blow; John F McCarthy; John E Zeber; Leah Gillon; C Raymond Bingham; Thomas Stavenger
Journal:  Med Care       Date:  2002-08       Impact factor: 2.983

View more
  39 in total

Review 1.  Neuroimaging correlates of aggression in schizophrenia: an update.

Authors:  Matthew J Hoptman; Daniel Antonius
Journal:  Curr Opin Psychiatry       Date:  2011-03       Impact factor: 4.741

2.  Translational Aspects of the Multidisciplinary Study of Metacognition.

Authors:  Silvia Chapman; Leigh E Colvin; Stephanie Cosentino
Journal:  Transl Issues Psychol Sci       Date:  2020-03

3.  Anosognosia in schizophrenia: hidden in plain sight.

Authors:  Douglas S Lehrer; Jennifer Lorenz
Journal:  Innov Clin Neurosci       Date:  2014-05

4.  Quality assessment of mental health care by people with severe mental disorders: a participatory research project.

Authors:  Angelo Barbato; Alessia Bajoni; Filippo Rapisarda; Vito D'Anza; Luigi Fabrizio De Luca; Cristiana Inglese; Sonia Iapichino; Fabrizio Mauriello; Barbara D'Avanzo
Journal:  Community Ment Health J       Date:  2013-12-08

5.  Predictors of medication non-adherence in Bulgarian outpatients with schizophrenia.

Authors:  Iglika Vassileva; Vihra Milanova; Turan Asan
Journal:  Community Ment Health J       Date:  2014-01-23

6.  Twelve-month prospective randomized study of pharmacists utilizing point-of-care testing for metabolic syndrome and related conditions in subjects prescribed antipsychotics.

Authors:  Mark E Schneiderhan; Sara M Shuster; Cynthia S Davey
Journal:  Prim Care Companion CNS Disord       Date:  2014-10-30

7.  Vestibular stimulation improves insight into illness in schizophrenia spectrum disorders.

Authors:  Philip Gerretsen; David D Pothier; Carolyn Falls; Maxine Armstrong; Thushanthi Balakumar; Hiroyuki Uchida; David C Mamo; Bruce G Pollock; Ariel Graff-Guerrero
Journal:  Psychiatry Res       Date:  2017-02-13       Impact factor: 3.222

8.  [Insight and Violent Behavior in a Cohort of Early Psychosis Patients].

Authors:  Valerie Moulin; Julie Palix; Luis Alameda; M Mehdi Gholamrezaee; Philipp S Baumann; Jacques Gasser; Julien Elowe; Alessandra Solida; Philippe Conus
Journal:  Can J Psychiatry       Date:  2017-06-28       Impact factor: 4.356

Review 9.  Insight in schizophrenia: a review.

Authors:  Marjorie Baier
Journal:  Curr Psychiatry Rep       Date:  2010-08       Impact factor: 5.285

10.  Medication adherence in schizophrenia: patient perspectives and the clinical utility of paliperidone ER.

Authors:  Michael Birnbaum; Zafar Sharif
Journal:  Patient Prefer Adherence       Date:  2008-02-02       Impact factor: 2.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.